Injection-site residues - Scientific guideline

This guidance addresses the assessment of potential consumer risk from veterinary drug residues remaining at intramuscular and subcutaneous injection sites and the elaboration of appropriate pre-slaughter withdrawal periods.

Keywords: Injection site residues, withdrawal periods

Current effective version

Adopted guideline on injection site residues - Revision 1

AdoptedLegal effective date: 01/08/2022Reference Number: EMA/CVMP/SWP/185470/2004 Rev.1

Document history

Adopted guideline on injection site residues - Revision 1

AdoptedLegal effective date: 01/08/2022Reference Number: EMA/CVMP/SWP/185470/2004 Rev.1

Overview of comments received on the guideline on injection site residues (EMA/CVMP/SWP/185470/2004) - Revision 1

Reference Number: EMA/CVMP/SWP/11010/2022

Draft guideline on injection site residue - Revision 1

Consultation dates: 15/10/2021 to 17/12/2021Draft: consultation closedReference Number: EMA/CVMP/SWP/185470/2004 Rev.1

Guideline on injection site residues - First version

AdoptedLegal effective date: 13/04/2005Reference Number: EMEA/CVMP/542/03-FINAL

Overview of comments received on draft guideline on injection site residues (EMEA/CVMP/542/03-FINAL)

Reference Number: EMEA/CVMP/209865/2004